Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 385 entries
View as:

TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05550025 Org: User:
Start: 12/17/21 End: 02/11/24 Due: 02/11/25

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05303727 Org: User:
Start: 08/31/22 End: 08/31/27 Due: 08/31/28

Collection of Peripheral Blood Mononuclear Cells From Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05560217 Org: User:
Start: 10/10/22 End: 09/10/25 Due: 09/10/26

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT06551896 Org: User:
Start: 08/15/24 End: 12/31/26 Due: 12/31/27

Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000).

Phase: N/A Priority: Normal
NCT ID: NCT05025930 Org: User:
Start: 10/01/21 End: 09/30/23 Due: 09/30/24

Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05892289 Org: User:
Start: 06/10/24 End: 12/10/26 Due: 12/10/27

Serum Progesterone Level in HRT-FET：a RCT

Phase: N/A Priority: Normal
NCT ID: NCT04248309 Org: User:
Start: 03/31/20 End: 04/30/21 Due: 04/30/22

Nipple-sparing Mastectomy in Combined With Buried Flap Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT05560633 Org: User:
Start: 05/01/15 End: 12/31/20 Due: 12/31/21

TEER for Severe DMR of Low to Intermediate Surgery Risk

Phase: N/A Priority: Normal
NCT ID: NCT06162780 Org: User:
Start: 01/01/24 End: 12/31/26 Due: 12/31/27

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06016400 Org: User:
Start: 06/14/21 End: 04/30/24 Due: 04/30/25

CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04452058 Org: User:
Start: 08/01/19 End: 12/30/22 Due: 12/30/23

Rheumatoid Arthritis Real-world Cohort Study in China (ReALSA)

Phase: N/A Priority: Normal
NCT ID: NCT06233929 Org: User:
Start: 03/01/24 End: 03/01/33 Due: 03/01/34

Gut Microbiome Dysbiosis in Sepsis-induced Coagulopathy

Phase: N/A Priority: Normal
NCT ID: NCT04525677 Org: User:
Start: 07/15/20 End: 07/15/21 Due: 07/15/22

Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis

Phase: N/A Priority: Normal
NCT ID: NCT06796231 Org: User:
Start: 07/12/24 End: 12/12/25 Due: 12/12/26

Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05545059 Org: User:
Start: 09/24/22 End: 03/31/23 Due: 03/31/24

Adelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT06016413 Org: User:
Start: 09/01/23 End: 12/01/26 Due: 12/01/27

Deep Learning-based sbORN Diagnostic Model

Phase: N/A Priority: Normal
NCT ID: NCT06463392 Org: User:
Start: 07/01/24 End: 12/31/30 Due: 12/31/31

The Analysis of Factors Causing Indwelling Urinary Catheter-related Infections in ICU Patients and Their Nursing Strategies

Phase: N/A Priority: Normal
NCT ID: NCT06295627 Org: User:
Start: 01/30/23 End: 01/15/24 Due: 01/15/25

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06575322 Org: User:
Start: 09/01/24 End: 03/01/27 Due: 03/01/28

Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF

Phase: N/A Priority: Normal
NCT ID: NCT02690870 Org: User:
Start: 01/31/17 End: 03/31/19 Due: 03/31/20

The Atherogenic Index of Plasma（AIP） in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT05973474 Org: User:
Start: 07/30/23 End: 07/31/24 Due: 07/31/25

A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06658587 Org: User:
Start: 11/01/24 End: 10/30/27 Due: 10/30/28

A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC

Phase: N/A Priority: Normal
NCT ID: NCT06632405 Org: User:
Start: 04/01/25 End: 03/31/27 Due: 03/31/28

Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT06897306 Org: User:
Start: 10/01/24 End: 01/20/25 Due: 01/20/26

Epidemiological Study of Out-of-hospital Cardiac Arrest in Shenzhen

Phase: N/A Priority: Normal
NCT ID: NCT06896006 Org: User:
Start: 01/01/11 End: 12/31/18 Due: 12/31/19